COVID-19 Testing Provider Curative Acquires KorvaLabs

COVID-19 testing startup Curative Inc. announced today that it has completed the acquisition of KorvaLabs, Inc., a CLIA certified and DEA licensed analytical laboratory based in San Dimas, California. The acquisition arrives just months after the two organizations first partnered to begin manufacturing and processing Curative’s oral fluid-based COVID-19 test. To date, the company has processed 245,371 tests in total with support from KorvaLabs, and continues to process approximately 14,000 on a daily basis. “KorvaLabs has been instrumental in enabling us to quickly scale our testing capacity and deliver accurate, easy-to-use oral fluid tests to thousands of people across the City and County of Los Angeles,” said Fred Turner, CEO and founder of Curative. “Curative has worked in close partnership with KorvaLabs for months now, so our decision to move forward with the acquisition just serves to formalize that relationship.”

Read the full article: COVID-19 Testing Provider Curative Acquires KorvaLabs //


Scroll to Top